MedTrace Logo

Does Neuromuscular Electrical Stimulation Benefit the Functional Ability of Elderly Patients With Chronic Obstructive Lung Disease

NCT05838911 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-04-30

No results posted yet for this study

Summary

Background: Patients with COPD often experience skeletal muscle dysfunction. For those who are unable or unwilling to undertake physical training, neuromuscular electrical stimulation (NMES) may provide an alternative method of exercise training.

Objective: To investigate the effects of adding neuromuscular electrical stimulation of gluteus maximus, quadriceps and calf muscles to chest physiotherapy, compared to chest physiotherapy alone, on muscles strength (gluteus max., quadriceps, calf muscles), femoral blood flow physical and pulmonary function in severe COPD Patients.

Conditions

  • Pulmonary Rehabilitation
  • Chronic Obstructive Lung Disease
  • Neuromuscular Electrical Stimulation
  • Pulmonary Function (FEV1/FVC)

Interventions

OTHER

Study Group chest physiotherapy program combined with neuromuscular electrical stimulation (NMES)

The patients in this group were received the same chest physiotherapy program combined with neuromuscular electrical stimulation of gluteus max., quadriceps, and calf muscles performed for 30 min /day for five days a week for three consecutive weeks.

OTHER

Control Group Chest physical therapy

The patients in this group were received the chest physiotherapy program for 20 min each day, for five days a week for three consecutive weeks

Sponsors & Collaborators

  • South Valley University

    collaborator OTHER

  • Beni-Suef University

    lead OTHER

Principal Investigators

  • Ibrahim I. I Abu zaid, PhD · Department of P.T for internal medicine, Faculty of Physical Therapy, South valley university, Qena, Egypt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-02
Primary Completion
2023-08-13
Completion
2023-08-13

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05838911 on ClinicalTrials.gov